Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jun;84(3):290-4.
doi: 10.1111/j.1440-1711.2006.01442.x.

Some Considerations on the Use of Peptides and mRNA for Therapeutic Vaccination Against Cancer

Affiliations
Review

Some Considerations on the Use of Peptides and mRNA for Therapeutic Vaccination Against Cancer

Hans-Georg Rammensee. Immunol Cell Biol. .

Abstract

Active immunization against existing cancer is a field that is currently in development and is associated with a number of problems. The potential use of peptides as minimal essential T-cell antigens and of mRNA as a novel form of antigen with advantages is discussed, with special consideration of practical aspects.

Similar articles

See all similar articles

Cited by 2 articles

LinkOut - more resources

Feedback